Paper Details 
Original Abstract of the Article :
Carbonic anhydrase inhibitor (CAI) side effects are common, but not well understood. Many ideas have surfaced on how to reduce these side effects, even though there is little scientific evidence to support some of the advice. One recommendation involves switching drugs when patients are intolerant o...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/s0161-6420(81)35040-4

データ提供:米国国立医学図書館(NLM)

Managing Side Effects of Carbonic Anhydrase Inhibitors: A Quest for Relief

Carbonic anhydrase inhibitors (CAIs) are a class of drugs commonly used to treat conditions such as glaucoma. However, they can also cause side effects, which can vary from person to person. This research explores strategies for managing side effects associated with CAIs, investigating the effectiveness of switching drugs, reducing dosage, and other approaches.

Finding Relief from CAI Side Effects

The study found that switching from acetazolamide to methazolamide could help manage side effects in some patients, but not all. The research suggests that other approaches, such as reducing dosage or gradually increasing dosage, may also be effective. This research provides valuable insights into the management of CAI side effects, highlighting the need for individualized treatment plans.

Understanding and Managing Side Effects

This research underscores the importance of understanding and managing side effects associated with CAI medications. The study highlights the need for individualized treatment plans, carefully considering the patient's specific needs and responses to medication. It is like a camel navigating the desert, adapting its route and pace to the challenges of the terrain.

Dr.Camel's Conclusion

This research explores strategies for managing side effects associated with carbonic anhydrase inhibitors (CAIs), investigating the effectiveness of switching drugs, reducing dosage, and other approaches. The study highlights the need for individualized treatment plans, carefully considering the patient's specific needs and responses to medication.

Date :
  1. Date Completed 1981-07-20
  2. Date Revised 2019-07-26
Further Info :

Pubmed ID

7231916

DOI: Digital Object Identifier

10.1016/s0161-6420(81)35040-4

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.